34 related articles for article (PubMed ID: 3120475)
1. Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects.
Kontoghiorghes GJ
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902402
[TBL] [Abstract][Full Text] [Related]
2. On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson's Disease.
García-Beltrán O; Urrutia PJ; Núñez MT
Antioxidants (Basel); 2023 Jan; 12(2):. PubMed ID: 36829773
[TBL] [Abstract][Full Text] [Related]
3. The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia.
Kontoghiorghes GJ; Kleanthous M; Kontoghiorghe CN
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020011. PubMed ID: 31934321
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in situ permeability of a 'second generation' hydroxypyridinone oral iron chelator: correlation with physico-chemical properties and oral activity.
Lowther N; Fox R; Faller B; Nick H; Jin Y; Sergejew T; Hirschberg Y; Oberle R; Donnelly H
Pharm Res; 1999 Mar; 16(3):434-40. PubMed ID: 10213376
[TBL] [Abstract][Full Text] [Related]
5. Platelet labelling with indium-hydroxypyridinone and indium-hydroxypyranone complexes.
Abeysinghe RD; Ellis BL; Porter JB
Eur J Nucl Med; 1994 Oct; 21(10):1141-7. PubMed ID: 7828625
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94.
Carthew P; Smith AG; Hider RC; Dorman B; Edwards RE; Francis JE
Biometals; 1994 Oct; 7(4):267-71. PubMed ID: 7812111
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the anti-inflammatory properties of hydroxypyridinones.
Hewitt SD; Hider RC; Sarpong P; Morris CJ; Blake DR
Ann Rheum Dis; 1989 May; 48(5):382-8. PubMed ID: 2730166
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of tyrosinase by pyridinones.
Hider RC; Lerch K
Biochem J; 1989 Jan; 257(1):289-90. PubMed ID: 2493243
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs.
Kontoghiorghes GJ
Toxicol Lett; 1995 Oct; 80(1-3):1-18. PubMed ID: 7482575
[TBL] [Abstract][Full Text] [Related]
10. [Current possibilities in the therapy of iron overload].
Cermák J
Vnitr Lek; 1994 Sep; 40(9):605-8. PubMed ID: 7975366
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of hydroxypyridone iron chelators in a mouse model.
Gyparaki M; Porter JB; Hirani S; Streater M; Hider RC; Huehns ER
Acta Haematol; 1987; 78(2-3):217-21. PubMed ID: 3120475
[TBL] [Abstract][Full Text] [Related]
12. Dose response studies using desferrioxamine and orally active chelators in a mouse model.
Kontoghiorghes GJ
Scand J Haematol; 1986 Jul; 37(1):63-70. PubMed ID: 3764334
[TBL] [Abstract][Full Text] [Related]
13. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
Kontoghiorghes GJ
Mol Pharmacol; 1986 Dec; 30(6):670-3. PubMed ID: 3785144
[TBL] [Abstract][Full Text] [Related]
14. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload.
Kontoghiorghes GJ; Barr J; Nortey P; Sheppard L
Am J Hematol; 1993 Apr; 42(4):340-9. PubMed ID: 8493983
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
Morel I; Cillard J; Lescoat G; Sergent O; Pasdeloup N; Ocaktan AZ; Abdallah MA; Brissot P; Cillard P
Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
